Novavax stock tanks on report of COVID-19 vaccine manufacturing troubles
October 20, 2021 at 11:16 AM EDT
The potential production problems with Novavax's vaccine could hamper the efforts of the COVAX initiative, which forecast in September that it will be able to provide low and middle-income countries 1.425 billion COVID-19 vaccine doses to by the end of the year and 2 billion doses by the first quarter of 2022.
